Researchers explored decades of data from more than 25,000 women, sharing their findings in JAMA Network Open.

The group’s work is focused on how signal processing technologies and machine learning can track the health of VADs and the patients who need them. 

Now that the company has gained FDA approval for multiple algorithms, Eko Health aims to reach as many patients as possible with its AI-powered devices.

Cardiovascular Business spoke with HRS President Kenneth Ellenbogen, MD, about two key initiatives the group is focused on this year.

Researchers developed an advanced AI model capable of extracting measurements from unprocessed CT images in seconds. It then uses those data to evaluate the patient's mortality risk if they underwent TAVR.

HRS President Kenneth Ellenbogen, MD, detailed some of the biggest trends in electrophysiology at Heart Rhythm 2024 in Boston. 

More than 60% of adults in the United States are expected to have at least one form of cardiovascular disease by 2050, according to new data published by the American Heart Association. Fortunately, evidence does suggest that healthier lifestyles are starting to become more common as time goes on.

According to a new proposal, using AI to evaluate CCTA results and quantify plaque buildup is “reasonable and medically necessary” in certain clinical scenarios.

A cardiologist in Billings, Montana, says her new-look practice was designed to reach patients faster and ditch unnecessary red tape. Patients pay an upfront fee, and insurance does not play a role in treatment decisions.

This move represents a pivot of sorts for Edwards; instead of pursuing a spin-off of its critical care business, the company is now doubling down on its commitment to develop new structural heart technologies. BD, meanwhile, says the transaction will deliver significant value.